Maya Martinez-Davis

MAYA MARTINEZ-DAVIS joined GSK in September 2019 to lead the $20B+ pharmaceuticals and vaccines businesses in the US and Puerto Rico as president of US Pharmaceutical. She brings more than fifteen years in the industry leading people, energizing teams, and delivering on strategy to expand markets in the US, Latin America, and beyond. Her strategic insight covers many therapeutic areas with deep expertise in oncology and specialty treatments as GSK prepares to launch multiple oncology medicines, and develop new respiratory, and immuno-inflammation medicines. She came to GSK from the role of regional president, Latin America, at EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany. Previously at EMD Serono, she was SVP of global oncology. Prior to this, she spent thirteen years at Pfizer leading various business units around the world including oncology and vaccines. Martinez-Davis earned her undergraduate degree from Saint Louis University and a Master Direccion Comercial y Marketing from the Instituto de Empresa. @gsk